Article

Integrating Serum Biomarkers and Genetic Polymorphisms for Alzheimer’s Disease Risk Screening

2025-06-19

Abstract excerpt

<h4>Objective</h4> Analyze the differences in the detection results of Alzheimer’s disease (AD) serum biomarkers and the expression of APOE and SLCO1B1 genotypes, then construct an AD diagnostic model integrating serum biomarkers with APOE and SLCO1B1 genotypes to enhance the sensitivity and specificity of AD screening. <h4>Methods</h4> Serum samples from 127 participants (41 AD, 39 cognitive impairments, 47 con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0c726ccb-60dd-578d-89c5-75da6af275ca
DOI: 10.1101/2025.06.17.25329820

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrating Serum Biomarkers and Genetic Polymorphisms for Alzheimer’s Disease Risk ScreeningDOI 10.1101/2025.06.17.25329820Read

Performance of Plasma Amyloid β, Total Tau and Neurofilament Light Chain Levels for Alzheimer’s Disease IdentificationSemantic proximity Read

Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unitSemantic proximity Read

Harmonization of CSF and imaging biomarkers for Alzheimer’s disease biomarkers: need and practical applications for genetics studies and preclinical classificationSemantic proximity Read

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read

An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.Semantic proximity Read

Endophenotype-based polygenic risk scores: Prediction of biomarker and clinical progression and dementiaSemantic proximity Read

A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groupsSemantic proximity Read

Genetic architecture of Alzheimer’s disease-related plasma biomarkersSemantic proximity Read

Optimal Combinations of Biomarkers to Determine AT(N) in the Alzheimer’s Disease Semantic proximity Read

Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.Semantic proximity Read

Multimodal Integration of Alzheimer's Plasma Biomarkers, MRI, and Genetic Risk for Individual Prediction of Cerebral Amyloid BurdenSemantic proximity Read